Abstract

Author SummaryTGF-β is a cytokine thought to be critical for the maintenance and function of tolerance in the immune system. In many studies the disruption of TGF-β signalling in CD4+ T cells (a type of white blood cell that coordinates immune responses) has resulted in autoimmune syndromes. We show here that the induced removal of this cytokine's receptor from these specialised blood cells results in an astonishingly mild outcome. Contrary to expectations, the number of regulatory T cells is actually increased, and we find that these cells are not dependent on TGF-β signalling. We also show that removal of the receptor from mature CD4+ T cells does not lead to lethal autoinflammation; only when we removed the receptor during development of the cells did we see the characteristic lethal multi-organ inflammation reported previously in constitutive models of TGF-β receptor ablation. In summary, our findings indicate that although TGF-β regulates maintenance of mature CD4+ T cells, its signals are dispensable for immune tolerance within this cell population.

Highlights

  • Transforming growth factor b (TGF-b1) is a cytokine that is expressed throughout the hematopoietic system

  • In many studies the disruption of TGF-b signalling in CD4+ T cells has resulted in autoimmune syndromes

  • The number of regulatory T cells is increased, and we find that these cells are not dependent on TGF-b signalling

Read more

Summary

Introduction

Transforming growth factor b (TGF-b1) is a cytokine that is expressed throughout the hematopoietic system. Mice deficient in TGF-b1 show hyperactivation and uncontrolled expansion of T cells leading to a lethal multi-organ autoimmune disorder [2]. Genetic ablation of TR2 in hematopoietic or, in T cells leads to lymphadenopathy, splenomegaly, and inflammation of various organs followed by death at 3 wk of age [9,10,11]. All these models of interrupted TR function suggest an essential, nonredundant role for TGF-b1 in the maintenance of T cell tolerance.

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.